# Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer

> **NCT03239613** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 84 (actual)

## Conditions studied

- Cervix Cancer
- Radiotherapy, Adjuvant
- Radiotherapy, Intensity-Modulated
- Hypofractionated Dose
- Chemotherapy, Concurrent

## Interventions

- **OTHER:** POHIM-CCRT

## Key facts

- **NCT ID:** NCT03239613
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-31
- **Primary completion:** 2023-04-28
- **Final completion:** 2023-04-28
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239613, "Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03239613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*